Hypotheses

In islets grafted into the liver, glucose released by nearby liver cells may suppress glucagon as blood sugar falls. Restoring glucagon by matching glucose around the graft to arterial glucose would distinguish this local sensing explanation.

Explains the gap: Does successful islet counterregulation without adrenergic signaling depend on hepatic glycogen state, so a graft that protects during one meal–activity transition causes substrate shortages during another?

The islet graft detects falling glucose, but the retained liver cannot supply enough. The hypothesis predicts that restoring liver fuel reserves improves glucose defense at both graft sites without changing the graft’s local glucose response.

Explains the gap: Does successful islet counterregulation without adrenergic signaling depend on hepatic glycogen state, so a graft that protects during one meal–activity transition causes substrate shortages during another?

In engrafted human islets, withdrawal of liver-derived extracellular adenosine triphosphate (ATP) would control glucagon release. Reproducing the response at fixed glucose, and eliminating it with constant ATP during falling glucose, would distinguish replacement control from modulation.

Explains the gap: Does successful islet counterregulation without adrenergic signaling depend on hepatic glycogen state, so a graft that protects during one meal–activity transition causes substrate shortages during another?

In liver islet grafts, meal-associated liver-cell expansion may narrow small blood vessels until activity-related pressure changes interrupt oxygen delivery and hormone release. A pressure threshold and rescue by raising pressure across vessel walls would distinguish this mechanical explanation.

Explains the gap: Does successful islet counterregulation without adrenergic signaling depend on hepatic glycogen state, so a graft that protects during one meal–activity transition causes substrate shortages during another?

In human islets, the hypothesis makes bile-acid exposure the lasting cause of altered hormone processing. Transferring the change with a measured bile-acid mixture and preventing it by interrupting its receptor would distinguish this explanation from immediate local glucose effects.

Explains the gap: Does successful islet counterregulation without adrenergic signaling depend on hepatic glycogen state, so a graft that protects during one meal–activity transition causes substrate shortages during another?

The hypothesis says islet grafts only appear to switch from protecting glucose supply to undermining it when unlike studies are combined. Repeated measurements in the same recipients would decide whether meal and liver glycogen conditions produce a reproducible graft-specific reversal.

Explains the gap: Does successful islet counterregulation without adrenergic signaling depend on hepatic glycogen state, so a graft that protects during one meal–activity transition causes substrate shortages during another?

In a perfused graft–retained-kidney preparation, replacement-driven venous loading would impair regional oxygen supply despite acceptable whole-organ measurements. Vessel narrowing and oxygen loss before tubular dysfunction, with prompt recovery after pressure release, would distinguish the mechanism.

Explains the gap: Can replacement tissue satisfy every prespecified delivery and clearance limit yet cause retained-organ dysfunction under combined mild stress through a venous-pressure collapse missed by those limits?

In perfused microvessels and vascularized tissue models, protein leakage could impair retained tissue despite adequate oxygen supply. Labeled-albumin escape before dysfunction and prevention by barrier restoration without blood-flow effects would distinguish this mechanism.

Explains the gap: Can replacement tissue satisfy every prespecified delivery and clearance limit yet cause retained-organ dysfunction under combined mild stress through a venous-pressure collapse missed by those limits?

In the retained endothelial–epithelial network, pressure would leave an electrical memory that suppresses function after delivery recovers. Erasing the measured voltage pattern must restore function; writing it into an unpressurized preparation must reproduce dysfunction.

Explains the gap: Can replacement tissue satisfy every prespecified delivery and clearance limit yet cause retained-organ dysfunction under combined mild stress through a venous-pressure collapse missed by those limits?

In retained tissue, brief oxygen shortages would leave a chemical imbalance that causes injury during recovery. Intermittent oxygen delivery should cause more delayed dysfunction than steady delivery, and selectively blocking mitochondrial oxidant production should prevent injury without correcting venous pressure.

Explains the gap: Can replacement tissue satisfy every prespecified delivery and clearance limit yet cause retained-organ dysfunction under combined mild stress through a venous-pressure collapse missed by those limits?

Repeated passage through replacement tissue may leave red blood cells less flexible, impairing retained organs during combined mild stress. Transfer of the defect by washed cells at normal venous pressure, and rescue with unconditioned cells, would distinguish a cell-carried injury from pressure itself.

Explains the gap: Can replacement tissue satisfy every prespecified delivery and clearance limit yet cause retained-organ dysfunction under combined mild stress through a venous-pressure collapse missed by those limits?

Within the specified exposure range, apparent harm from tissue replacement reflects measurement and selection effects. The claim predicts an effect equivalent to zero under controlled testing; reproducible, intervention-linked impairment on independent functional measures would reject it.

Explains the gap: Can replacement tissue satisfy every prespecified delivery and clearance limit yet cause retained-organ dysfunction under combined mild stress through a venous-pressure collapse missed by those limits?

In perfused-organ systems, liver-exported glutamine is proposed to increase kidney oxygen demand beyond supply. Removing and restoring glutamine should reverse and restore that demand; increasing oxygen should rescue adenosine triphosphate (ATP) and clearance without changing nitrogen transfer.

Explains the gap: Does stronger hepatic ammonia scavenging protect replacement tissue by transferring a damaging nitrogen burden to retained kidneys, making normal circulating ammonia a sign of concealed failure?

Restoring the collecting-duct ammonia transporter RhCG should shift labeled nitrogen into urine and reduce kidney dysfunction under matched conditions. Normal nitrogen partitioning and failure of verified transport restoration to rescue function would reject the claim.

Explains the gap: Does stronger hepatic ammonia scavenging protect replacement tissue by transferring a damaging nitrogen burden to retained kidneys, making normal circulating ammonia a sign of concealed failure?

In animal or discarded-organ preparations, glutamine-associated swelling would impair oxygen delivery by compressing small blood vessels. Restoring oxygenation and filtration through decompression, with glutamine delivery and nitrogen processing unchanged, would distinguish this mechanism.

Explains the gap: Does stronger hepatic ammonia scavenging protect replacement tissue by transferring a damaging nitrogen burden to retained kidneys, making normal circulating ammonia a sign of concealed failure?

In coupled kidney epithelial cells, a glutamine pulse could leave an electrical memory of low clearance after metabolic conditions normalize. Lasting electrical restoration of normal clearance, followed by electrical reinstatement of low clearance, would distinguish this claim.

Explains the gap: Does stronger hepatic ammonia scavenging protect replacement tissue by transferring a damaging nitrogen burden to retained kidneys, making normal circulating ammonia a sign of concealed failure?

In species-matched kidney perfusion systems, the hypothesis predicts that ammonia causes injury through the alternative complement pathway. Removing factor B should prevent injury under matched nitrogen handling and oxygenation; adding it back should restore injury.

Explains the gap: Does stronger hepatic ammonia scavenging protect replacement tissue by transferring a damaging nitrogen burden to retained kidneys, making normal circulating ammonia a sign of concealed failure?

In a linked-organ platform, stronger liver ammonia removal would change kidney fuel use without causing damage. Glutamine subtraction and add-back would decide whether glutamine causes a reproducible loss of kidney function.

Explains the gap: Does stronger hepatic ammonia scavenging protect replacement tissue by transferring a damaging nitrogen burden to retained kidneys, making normal circulating ammonia a sign of concealed failure?

In an aged-animal reconstruction model, loading order is proposed to leave a lasting state in the matrix and fibroblasts where replacement meets retained tissue. Transfer of the injury-related difference through cell-free matrix, and its loss after cross-link removal, would distinguish this claim.

Explains the gap: Can earlier loading of a recovering replacement reduce total injury by preventing retained-tissue overload, and does the safest loading schedule depend on the order rather than the sum of exposures?

In animals, changing the brain’s representation of a protected limb would shift structural injury despite matched tissue strain, blood supply, oxygenation, and circulating signals. Improved tissue breaking strength outside the body would distinguish structural protection from changes in pain or movement.

Explains the gap: Can earlier loading of a recovering replacement reduce total injury by preventing retained-tissue overload, and does the safest loading schedule depend on the order rather than the sum of exposures?

The hypothesis says early gentle contractions restore lymph drainage, preventing swelling and workload transfer to retained tissue. Testing in animals would ask whether drainage treatment reproduces early-loading benefits under matched exposures, and whether collector dysfunction removes them.

Explains the gap: Can earlier loading of a recovering replacement reduce total injury by preventing retained-tissue overload, and does the safest loading schedule depend on the order rather than the sum of exposures?

Replacement repair and compensating retained muscle share a limited fuel supply. With mechanical exposure matched on both sides, changing when identical energy and amino-acid provision arrives would change or reverse the loading-order effect if competition for fuel explains the injury.

Explains the gap: Can earlier loading of a recovering replacement reduce total injury by preventing retained-tissue overload, and does the safest loading schedule depend on the order rather than the sum of exposures?

In aged-animal tissue reconstruction, early activity or protection would program lasting injury responses in blood-forming cells. Different injury responses after donor-cell transfer into recipients with identical loading would distinguish this claim from memory stored at the mechanical interface.

Explains the gap: Can earlier loading of a recovering replacement reduce total injury by preventing retained-tissue overload, and does the safest loading schedule depend on the order rather than the sum of exposures?

Apparent loading-order effects reflect unequal local mechanical exposure and healing stage. Accounting for both should remove sequence effects; reproducible transfer through isolated matrix or hematopoietic cells, or selective rescue at matched exposure, would reject this explanation.

Explains the gap: Can earlier loading of a recovering replacement reduce total injury by preventing retained-tissue overload, and does the safest loading schedule depend on the order rather than the sum of exposures?

In stable recipients and an instrumented preclinical circulation, the hypothesis places instability in overlapping corrective responses. A model fitted before intervention must predict whether separately changing correction strength and feedback delay improves stability across heat, posture, and rehydration.

Explains the gap: Could faster accommodation in replaced tissue destabilize retained circulation, making deliberately slower local correction safer during heat, rehydration, and standing?

The hypothesis says rapid tissue adjustment overwhelms the blood vessel barrier, leaving fluid outside circulation and impairing oxygen delivery. It predicts that leakage precedes the delivery deficit and that preserving the barrier removes the deficit without changing feedback timing.

Explains the gap: Could faster accommodation in replaced tissue destabilize retained circulation, making deliberately slower local correction safer during heat, rehydration, and standing?

Retained dermal and skeletal-muscle interstitial matrices could drive repeated circulation swings. In a continuously perfused, denervated tissue circuit, changing matrix prestress alone would switch stable settling to volume-flow oscillations despite fixed hormones and verified endothelial permeability.

Explains the gap: Could faster accommodation in replaced tissue destabilize retained circulation, making deliberately slower local correction safer during heat, rehydration, and standing?

In replaced tissue, fast accommodation may restore blood flow before red blood cells can release enough oxygen. The deciding observation is whether faster oxygen release removes the functional disadvantage of fast versus slow accommodation without changing pressure damping.

Explains the gap: Could faster accommodation in replaced tissue destabilize retained circulation, making deliberately slower local correction safer during heat, rehydration, and standing?

The hypothesis says rapid oral rehydration activates gut-liver sensing independently of graft adjustment. In preclinical testing, selectively interrupting portal salt-and-water sensing would eliminate the fast-drinking effect while preserving responses to matched fluid delivery outside the gut.

Explains the gap: Could faster accommodation in replaced tissue destabilize retained circulation, making deliberately slower local correction safer during heat, rehydration, and standing?

During mild challenges, faster adjustment in replaced tissue would cause no reproducible disadvantage in brain blood flow, muscle oxygen use, cognition, or movement. Apparent delays would follow the instruments; replicated physiological deficits with functional impairment would refute the claim.

Explains the gap: Could faster accommodation in replaced tissue destabilize retained circulation, making deliberately slower local correction safer during heat, rehydration, and standing?

After infection control, correcting absorbed energy and indispensable amino acid deficits should improve muscle net protein balance before C-reactive protein normalizes, without requiring cytokines to fall. Continued muscle protein breakdown despite sufficient absorbed nutrients would reject this claim.

Explains the gap: After infection control, does nutrient deficit itself sustain the apparent inflammatory state, causing biomarker-guided caution to prolong muscle breakdown rather than protect recovery?

Muscle breakdown persists despite sufficient nutrients because glucocorticoid signaling stays active. In a resolved-infection animal model, interrupting the muscle receptor should reverse excess breakdown; complete nutritional rescue with unchanged receptor activity would argue against dominance.

Explains the gap: After infection control, does nutrient deficit itself sustain the apparent inflammatory state, causing biomarker-guided caution to prolong muscle breakdown rather than protect recovery?

The hypothesis places persistent muscle loss in the mechanical state of its surrounding matrix. Affected matrix would transfer impaired protein retention and contractile recovery to healthy engineered muscle under matched conditions; normalizing its mechanics would remove the effect.

Explains the gap: After infection control, does nutrient deficit itself sustain the apparent inflammatory state, causing biomarker-guided caution to prolong muscle breakdown rather than protect recovery?

In recovered animals, a stored neural state could sustain muscle protein breakdown despite adequate nutrition. Brief silencing of illness-tagged neurons would durably restore muscle protein balance; reactivation would restart breakdown while nutrients, activity, steroids, and inflammation remain matched.

Explains the gap: After infection control, does nutrient deficit itself sustain the apparent inflammatory state, causing biomarker-guided caution to prolong muscle breakdown rather than protect recovery?

In a defined-community animal model with equal total absorbed nutrition, feeding pulses are predicted to drive bacteria–phage cycles that sustain muscle breakdown. Continuous feeding should weaken the sequence; removing and restoring the phage should abolish and restore it.

Explains the gap: After infection control, does nutrient deficit itself sustain the apparent inflammatory state, causing biomarker-guided caution to prolong muscle breakdown rather than protect recovery?

In the specified post-control interval, high C-reactive protein (CRP) and apparent muscle loss do not indicate continuing excess muscle protein breakdown caused by nutrient deficit. Repeated muscle measurements test this claim; confirmed negative muscle balance followed by contractile-tissue loss would refute it.

Explains the gap: After infection control, does nutrient deficit itself sustain the apparent inflammatory state, causing biomarker-guided caution to prolong muscle breakdown rather than protect recovery?

At the graft-host interface—the connection transmitting force between graft and host—power gains may accompany worsening movement dependence. The hypothesis predicts that redistributing load preserves repeated-task independence at matched muscle activation and metabolic work, despite unchanged sensory error.

Explains the gap: Can power-first rehabilitation improve measured capacity while deepening everyday dependence because activity advances faster than sensory recalibration and graft-interface recovery?

The hypothesis says learned sensory errors keep recipients dependent after tissue mechanics recover. Correcting sensory timing and spatial mapping would restore independent movement without further power gain; reversing a safe feedback distortion would produce direction-specific learned responses.

Explains the gap: Can power-first rehabilitation improve measured capacity while deepening everyday dependence because activity advances faster than sensory recalibration and graft-interface recovery?

After power-first rehabilitation, retained fluid at the graft-host boundary could restrict movement despite restored power. Improved drainage restoring repeated-task mobility too quickly for collagen remodeling, without correcting sensory adaptation, would support this mechanism.

Explains the gap: Can power-first rehabilitation improve measured capacity while deepening everyday dependence because activity advances faster than sensory recalibration and graft-interface recovery?

Muscles may gain maximal power while incompletely replenished energy stores limit successive everyday tasks. Restoring those stores should abolish repeated-task failure without changing maximal power; disability persisting after verified energy recovery would refute this as the dominant explanation.

Explains the gap: Can power-first rehabilitation improve measured capacity while deepening everyday dependence because activity advances faster than sensory recalibration and graft-interface recovery?

In a preclinical replacement model, circulating vesicles carrying ribonucleic acid (RNA) would transfer learned movement errors beyond the trained nervous system. Opposite directional movement aftereffects in untrained recipients, matching donor training and reproduced by defined RNA cargo, would distinguish the claim.

Explains the gap: Can power-first rehabilitation improve measured capacity while deepening everyday dependence because activity advances faster than sensory recalibration and graft-interface recovery?

Apparent gains in capacity and increased dependence arise from test practice, assistance, reporting and task exposure. The hypothesis predicts no meaningful excess dependence after these are controlled; persistent assistance need on blinded objective tasks would reject it.

Explains the gap: Can power-first rehabilitation improve measured capacity while deepening everyday dependence because activity advances faster than sensory recalibration and graft-interface recovery?

A stable timing offset helps recovery by keeping combined oxygen demand within delivery capacity. The claim is tested by measuring demand and delivery: reducing peak rehabilitation demand while preserving total work should erase the offset advantage; persistence with spare delivery capacity would refute it.

Explains the gap: Could synchronizing all recovering tissues worsen recovery by concentrating demand, making a stable phase offset between feeding, rehabilitation, and sleep safer than maximal alignment?

In an adult inducible graft model with basal function preserved, suppressing the graft's own clock would improve cognitive and muscle recovery beyond the best timing adjustment, with demand, perfusion and sleep matched. Restoring the clock would restore the penalty; no advantage would reject the strong claim.

Explains the gap: Could synchronizing all recovering tissues worsen recovery by concentrating demand, making a stable phase offset between feeding, rehabilitation, and sleep safer than maximal alignment?

In barrier models and animals, aligned schedules are proposed to increase brain drug exposure during restorative sleep, impairing cognition and rehabilitation. Matched unbound plasma exposure tests this claim; no exposure difference with adequate transporter measurement rejects it.

Explains the gap: Could synchronizing all recovering tissues worsen recovery by concentrating demand, making a stable phase offset between feeding, rehabilitation, and sleep safer than maximal alignment?

In retained or reconstructed muscle-tendon interfaces, meal-related fluid shifts and rehabilitation loading may leave strain that disrupts sleep and next-day function. The claim predicts that reducing interface strain while preserving metabolic work removes the sleep/cognition penalty.

Explains the gap: Could synchronizing all recovering tissues worsen recovery by concentrating demand, making a stable phase offset between feeding, rehabilitation, and sleep safer than maximal alignment?

Meal timing could make microbial products circulate during sleep or rehabilitation recovery and impair restoration. The decisive test is whether removing the implicated microbial pathway removes the penalty and restoring its metabolite pulse at the harmful phase brings it back.

Explains the gap: Could synchronizing all recovering tissues worsen recovery by concentrating demand, making a stable phase offset between feeding, rehabilitation, and sleep safer than maximal alignment?

Schedules shift temporary performance rhythms, making fixed-clock tests suggest slower recovery. The explanation holds if differences disappear with testing balanced across biological phases and matched for time since meals or exercise, while everyday function and restoration remain equivalent.

Explains the gap: Could synchronizing all recovering tissues worsen recovery by concentrating demand, making a stable phase offset between feeding, rehabilitation, and sleep safer than maximal alignment?

Mature red blood cells could carry hidden recovery states left by the order of mild challenges. Different oxygen-delivery deficits in microvascular chips, followed by transfer of the donor's order-specific effect to an unexposed animal through these cells, would test their sufficiency.

Explains the gap: When every monitored domain appears recovered, can reversing the order of identical mild challenges reveal hidden biological memory that invalidates baseline return as a recovery criterion?

In retained calf muscle, challenge order leaves different muscle stiffness and slack length—the length before tension develops—despite restored vital signs. Passive movement that equalizes these properties would immediately erase the mobility order effect; persistence would reject the explanation.

Explains the gap: When every monitored domain appears recovered, can reversing the order of identical mild challenges reveal hidden biological memory that invalidates baseline return as a recovery criterion?

Associative learning may preserve challenge history after peripheral recovery. In a mild-challenge crossover study, changing learned cues should alter responses before the next challenge; an effect that follows physical history despite successful cue relearning would reject this mechanism.

Explains the gap: When every monitored domain appears recovered, can reversing the order of identical mild challenges reveal hidden biological memory that invalidates baseline return as a recovery criterion?

Meal-first and walking-first histories leave different local muscle glycogen stores despite apparent recovery, impairing later contractions. The hypothesis is rejected if local depletion is absent or the order effect persists after verified restoration.

Explains the gap: When every monitored domain appears recovered, can reversing the order of identical mild challenges reveal hidden biological memory that invalidates baseline return as a recovery criterion?

Sodium stored between cells in skin and muscle could preserve challenge history after apparent recovery. Tissue sodium and repeated blood-flow measurements would test whether later deficits follow reservoir relaxation and disappear when the reservoir is equalized.

Explains the gap: When every monitored domain appears recovered, can reversing the order of identical mild challenges reveal hidden biological memory that invalidates baseline return as a recovery criterion?

In participants receiving identical mild challenges in opposite orders, apparent lasting effects arise from timing and measurement. An objective deficit reproduced after these controls and changed by an intervention targeting its biological source would reject this claim.

Explains the gap: When every monitored domain appears recovered, can reversing the order of identical mild challenges reveal hidden biological memory that invalidates baseline return as a recovery criterion?

The hypothesis claims that regulatory T cells leave graft support cells with an electrical memory that protects infected and transformed cells. After the regulatory cells disappear, resetting and reinstating the voltage pattern would switch immune killing on and off.

Explains the gap: Does donor-targeted local tolerance create a protected niche where infected or transformed graft cells survive despite preserved systemic immunity?

In graft tissue, disconnected paths may keep capable immune cells from reaching infected or transformed cells. Changing path connectivity or placing immune cells inside isolated pockets would restore clearance; normal access despite delayed clearance would refute the claim.

Explains the gap: Does donor-targeted local tolerance create a protected niche where infected or transformed graft cells survive despite preserved systemic immunity?

A persistent endothelial Fas ligand (FasL) program in graft microvessels would protect infected and transformed cells by killing incoming cytotoxic lymphocytes. Blocking this program or delivering effectors beyond the endothelium would restore clearance; normal transit and survival would falsify the gate.

Explains the gap: Does donor-targeted local tolerance create a protected niche where infected or transformed graft cells survive despite preserved systemic immunity?

In perfused graft cultures, local tolerance would let abnormal cells survive despite normal immune-cell contact. Restoring local acidity, fuel availability and lactate clearance would restore killing; recreating the metabolic gradient would reverse that rescue.

Explains the gap: Does donor-targeted local tolerance create a protected niche where infected or transformed graft cells survive despite preserved systemic immunity?

The hypothesis says local graft tolerance leaves a body-wide immune blind spot for abnormal-cell antigens. Impaired responses to those same targets inside and outside the graft would support it; normal surveillance at a remote site would falsify it.

Explains the gap: Does donor-targeted local tolerance create a protected niche where infected or transformed graft cells survive despite preserved systemic immunity?

Under the tested conditions, local immune tolerance preserves normal graft tissue without delaying pathogen elimination or transformed-cell killing. Apparent persistence disappears with direct survival measurements; reproducible excess viable abnormal cells would falsify the claim.

Explains the gap: Does donor-targeted local tolerance create a protected niche where infected or transformed graft cells survive despite preserved systemic immunity?

In human organoids, restoring DNA building blocks specifically in normal repair cells should prevent new abnormal descendants after early termination of Yes-associated protein (YAP) activity. Rescue without delaying surveillance, even in immune-free cultures, would support the claim.

Explains the gap: Could terminating regeneration earlier increase malignant escape by destabilizing healing cells, and can surveillance timed to repair completion avoid that reversal?

In stretchable organoid platforms, this hypothesis links incomplete tissue boundaries to nuclear rupture and abnormal cell lineages. Changing boundary defects or strain under matched conditions, then testing temporary load redistribution, would distinguish a mechanical cause.

Explains the gap: Could terminating regeneration earlier increase malignant escape by destabilizing healing cells, and can surveillance timed to repair completion avoid that reversal?

In engineered epithelia, the hypothesis predicts that switching tissue voltage patterns reverses natural killer cell target selection within minutes despite matched receptor engagement. A reversal before other recovery would support an electrical permission signal for recognition.

Explains the gap: Could terminating regeneration earlier increase malignant escape by destabilizing healing cells, and can surveillance timed to repair completion avoid that reversal?

If this mechanism is right, early immune surveillance misses abnormal cells because they shed surface stress labels. Preventing that shedding should restore elimination without changing repair timing, normal-cell DNA damage or boundary mechanics; the benefit should require natural killer cells and their stress-label receptor.

Explains the gap: Could terminating regeneration earlier increase malignant escape by destabilizing healing cells, and can surveillance timed to repair completion avoid that reversal?

Normal repair cells may keep pre-existing abnormal clones from expanding by competing for shared space and resources. Preserving viable, non-expanding competitors should prevent that expansion; separating them from the shared niche should remove the protection.

Explains the gap: Could terminating regeneration earlier increase malignant escape by destabilizing healing cells, and can surveillance timed to repair completion avoid that reversal?

Early repair termination would inflate abnormal-cell percentages by reducing normal-cell numbers and prolonging reversible stress signals. Whole-volume counts and tracking cell descendants would remove the apparent increase; a confirmed rise in viable abnormal descendants would refute it.

Explains the gap: Could terminating regeneration earlier increase malignant escape by destabilizing healing cells, and can surveillance timed to repair completion avoid that reversal?

In animal grafts, a brief local boost to dead-cell engulfment and digestion would allow lasting recovery of both graft and retained organs. The deciding pattern is fewer dead cells first, less inflammatory output next, and restored clearance in retained organs afterward.

Explains the gap: After infection clears, does a brief restoration of graft-local efferocytosis permanently release both graft and retained organs from low function, or does retained-organ clearance failure recreate the trap?

Removing the active substances from circulating plasma could restore lasting recovery in both the graft and retained organs if their clearance tissue remains viable. Returning the isolated substances at their measured pretreatment free concentration would bring dysfunction back.

Explains the gap: After infection clears, does a brief restoration of graft-local efferocytosis permanently release both graft and retained organs from low function, or does retained-organ clearance failure recreate the trap?

In an accessible animal graft, confined tissue fluid could sustain poor function after infection clears. Brief, reversible pressure relief would restore small-vessel blood flow before dead-cell burden or dissolved blood substances change, with graft and retained-organ recovery lasting after support stops.

Explains the gap: After infection clears, does a brief restoration of graft-local efferocytosis permanently release both graft and retained organs from low function, or does retained-organ clearance failure recreate the trap?

An infection-tagged group of neurons could maintain dysfunction in a graft and the host's retained organs. Testing in mice would ask whether resetting that group durably restores both organs and whether reactivating it recreates dysfunction after peripheral recovery.

Explains the gap: After infection clears, does a brief restoration of graft-local efferocytosis permanently release both graft and retained organs from low function, or does retained-organ clearance failure recreate the trap?

After infection, retained clearance epithelium may remain unable to power transport despite restored supplies. Persistent defects outside the host, followed by transport recovery after a brief mitochondrial repair treatment ends and joint recovery in the host, would distinguish this claim.

Explains the gap: After infection clears, does a brief restoration of graft-local efferocytosis permanently release both graft and retained organs from low function, or does retained-organ clearance failure recreate the trap?

The hypothesis says graft and retained organs recover separately after infection, while treatment changes and outcome assessment make recovery look linked. Reproducible delayed improvement in an untreated compartment after a localized pulse would reject this account.

Explains the gap: After infection clears, does a brief restoration of graft-local efferocytosis permanently release both graft and retained organs from low function, or does retained-organ clearance failure recreate the trap?

In microfluidic interfaces and animal studies, persistent injury would reflect a self-maintaining drainage blockage. A temporary drainage bypass should produce recovery that lasts after removal; continued repair despite restored transport, oxygen delivery and viable tissue would reject this explanation.

Explains the gap: Can interface hydraulic resistance lock a resolved compatibility flare into chronic care dependence, even after alloimmune activity returns to baseline?

The hypothesis says stored tissue tension sustains repair after a flare. In a platform that controls tension and fluid conductance independently, releasing tension should end repair and repeated injury; improving fluid passage alone should fail.

Explains the gap: Can interface hydraulic resistance lock a resolved compatibility flare into chronic care dependence, even after alloimmune activity returns to baseline?

In electrically coupled recipient boundary cells, a membrane-voltage pattern could sustain repair after a flare resolves. Briefly erasing and reinstating that pattern would have to stop and restart lasting repair without changing transport, tissue mechanics, energy supply, or donor-directed immunity.

Explains the gap: Can interface hydraulic resistance lock a resolved compatibility flare into chronic care dependence, even after alloimmune activity returns to baseline?

The hypothesis places lasting dysfunction in surviving boundary cells: defective mitochondrial genomes expand and limit adenosine triphosphate (ATP), the cell’s usable energy. Reducing the implicated variant must restore energy production and end repair without changing interface geometry.

Explains the gap: Can interface hydraulic resistance lock a resolved compatibility flare into chronic care dependence, even after alloimmune activity returns to baseline?

Continued exposure to calcineurin inhibitors—drugs that suppress immune activity—may sustain tissue dysfunction. Recovery after replacing the suspected toxic drug mechanism, with donor-reactive immune suppression matched, and renewed dysfunction on preclinical rechallenge would distinguish this explanation.

Explains the gap: Can interface hydraulic resistance lock a resolved compatibility flare into chronic care dependence, even after alloimmune activity returns to baseline?

The hypothesis says missed local immune attack explains continuing care dependence. Dense sampling in engineered tissues and animal grafts would test whether immune activity precedes sustained injury and whether suppressing it permits durable recovery without restoring transport directly.

Explains the gap: Can interface hydraulic resistance lock a resolved compatibility flare into chronic care dependence, even after alloimmune activity returns to baseline?

In an aged-animal graft model, limited donor-directed immune killing may preserve graft quality and recovery. Removing those cells should increase donor-cell senescence and worsen recovery; restoring them or selectively clearing senescent donor cells should rescue it.

Explains the gap: Is successful graft acceptance the wrong organizing endpoint if cumulative recovery burden predicts autonomy loss while rejection, infection, and cancer meters remain reassuring?

In graft recipients, successive procedures may outpace muscle recovery and cause dependence. Recovery-based spacing should reduce six-month mobility and independence deficits; independently randomized muscle preservation should weaken that spacing effect without changing care hours.

Explains the gap: Is successful graft acceptance the wrong organizing endpoint if cumulative recovery burden predicts autonomy loss while rejection, infection, and cancer meters remain reassuring?

Near graft boundaries, repeated procedures may distort lymphatic vessels so activity overwhelms fluid drainage. Rapid improvement in clearance and task endurance after a reversible drainage intervention would support this claim; normalized drainage without better endurance would reject it as dominant.

Explains the gap: Is successful graft acceptance the wrong organizing endpoint if cumulative recovery burden predicts autonomy loss while rejection, infection, and cancer meters remain reassuring?

Recipients retain usable physical capacity but learn not to use it independently. A randomized trial of graded mastery feedback and gradually reduced caregiver assistance would test for lasting gains in independent daily activity without preceding gains in evoked force, muscle mass, or drainage.

Explains the gap: Is successful graft acceptance the wrong organizing endpoint if cumulative recovery burden predicts autonomy loss while rejection, infection, and cancer meters remain reassuring?

Care schedules that leave less uninterrupted time undermine independence. Consolidating care while matching total care minutes, treatment efficacy, sleep opportunity, and transport time would improve independent task completion within days, without changes in muscle force or tissue state.

Explains the gap: Is successful graft acceptance the wrong organizing endpoint if cumulative recovery burden predicts autonomy loss while rejection, infection, and cancer meters remain reassuring?

In the studied recipient population, care burden would reflect existing illness and biased measurement rather than cause lost independence. Reducing verified care fragmentation or workload would change recorded burden without meaningfully changing independently assessed daily function.

Explains the gap: Is successful graft acceptance the wrong organizing endpoint if cumulative recovery burden predicts autonomy loss while rejection, infection, and cancer meters remain reassuring?

In clinically indicated reconstruction recipients, temporary force limits help only with movement errors that retrain control. Better foot placement and stability during a second task after perturbation training, with context-dependent transfer and directional aftereffects, would distinguish this explanation.

Explains the gap: Could restoring less usable force initially preserve more lifetime mobility than maximizing replacement output, because sensorimotor recalibration and retained connective-tissue adaptation require different loading schedules?

In an aged reconstruction model, progressive loading is predicted to stiffen retained tendons while shortening fatigue life—the number of loading cycles before failure. Testing tendons outside the body under identical stress waveforms would distinguish tissue damage from neural, vascular or metabolic effects.

Explains the gap: Could restoring less usable force initially preserve more lifetime mobility than maximizing replacement output, because sensorimotor recalibration and retained connective-tissue adaptation require different loading schedules?

In an animal reconstruction model, pressure-driven fluid buildup could explain instability despite restored force. Changing pressure around nerves should change internal pressure, sensory conduction and instability together; pressure relief should restore conduction before structural adaptation or relearning.

Explains the gap: Could restoring less usable force initially preserve more lifetime mobility than maximizing replacement output, because sensorimotor recalibration and retained connective-tissue adaptation require different loading schedules?

In supported plantar-flexion or knee-extension tasks, retained stabilizing muscles run out of energy. Recovery between bouts should prevent instability; corrective force should return within minutes as metabolism recovers, with predictions then validated in instrumented walking.

Explains the gap: Could restoring less usable force initially preserve more lifetime mobility than maximizing replacement output, because sensorimotor recalibration and retained connective-tissue adaptation require different loading schedules?

The hypothesis attributes gait instability after exertion to retained cardiovascular regulation failing to sustain brain blood flow. It predicts that maintaining central circulation restores pressure and cerebral-flow indices while reducing symptoms and stepping errors without extra practice or tendon adaptation.

Explains the gap: Could restoring less usable force initially preserve more lifetime mobility than maximizing replacement output, because sensorimotor recalibration and retained connective-tissue adaptation require different loading schedules?

Within clinically acceptable progression, recipients given less usable force appear to preserve mobility because they walk less. A randomized comparison with equal rehabilitation contact and blinded assessment tests whether any lasting benefit survives comparable walking exposure.

Explains the gap: Could restoring less usable force initially preserve more lifetime mobility than maximizing replacement output, because sensorimotor recalibration and retained connective-tissue adaptation require different loading schedules?

The hypothesis places failure at the mucus and epithelial barrier: meal and sleep shifts align microbial entry with treatment-induced loss of local antimicrobial defense. Separating these peaks should restore containment even when their daily totals stay matched.

Explains the gap: Can ordinary meal and sleep shifts synchronize barrier leakage with maximal local immune suppression, producing infections that neither average drug exposure nor average inflammation predicts?

In recipient immune cells and graft-interface organotypic cultures, the hypothesis predicts that briefly resetting tissue voltage restores microbial killing for several cycles after stimulation ends. The decisive observation is lasting rescue while other specified influences remain equivalent.

Explains the gap: Can ordinary meal and sleep shifts synchronize barrier leakage with maximal local immune suppression, producing infections that neither average drug exposure nor average inflammation predicts?

In reporter mice, impaired intestinal lymph flow would explain failed microbial containment. Restoring flow should speed arrival at draining lymph nodes and containment without changing microbial entry, tissue drug effects, or immune cells’ own killing ability; slowing flow should reproduce failure.

Explains the gap: Can ordinary meal and sleep shifts synchronize barrier leakage with maximal local immune suppression, producing infections that neither average drug exposure nor average inflammation predicts?

The hypothesis says meal and sleep shifts drain glycogen, a stored fuel, in antimicrobial neutrophils. Restoring that fuel should restore microbial killing and containment despite unchanged schedules, barrier entry and tissue drug effects.

Explains the gap: Can ordinary meal and sleep shifts synchronize barrier leakage with maximal local immune suppression, producing infections that neither average drug exposure nor average inflammation predicts?

Meal and sleep shifts may change the invasive state of intestinal microbial communities. The deciding observation is whether equal viable microbial doses transfer different invasion potential from vulnerable and protected phases into recipients with matched host conditions.

Explains the gap: Can ordinary meal and sleep shifts synchronize barrier leakage with maximal local immune suppression, producing infections that neither average drug exposure nor average inflammation predicts?

The hypothesis says sparse sampling and misleading drug and microbial measurements create an apparent infection window. It predicts that balanced sampling and direct tissue and viable-organism measurements erase the interaction; replicated increases in viable spread and injury would refute it.

Explains the gap: Can ordinary meal and sleep shifts synchronize barrier leakage with maximal local immune suppression, producing infections that neither average drug exposure nor average inflammation predicts?

In an inducible, graft-restricted animal experiment, suppressing the graft’s own rhythm would protect cognition through rapid feedback. Protection without reduced output, followed by renewed schedule sensitivity when oscillation is restored, would distinguish this mechanism.

Explains the gap: Can individually adequate graft output and retained clearance become jointly unsafe after schedule disruption because their clocks cannot relock before cognition and self-care deteriorate?

Retained clearance may handle separate challenges but fail when their loads overlap. Serial metabolite sampling and tracer kinetics test whether accumulated solute predicts cognitive deficits and whether smaller pulses restore function without changing clock alignment.

Explains the gap: Can individually adequate graft output and retained clearance become jointly unsafe after schedule disruption because their clocks cannot relock before cognition and self-care deteriorate?

The hypothesis says schedule disruption lets a neuroactive substance accumulate in the brain despite adequate clearance elsewhere. It predicts increased brain-to-plasma exposure and restored cognition when transport out of the brain is restored in a mechanistic model.

Explains the gap: Can individually adequate graft output and retained clearance become jointly unsafe after schedule disruption because their clocks cannot relock before cognition and self-care deteriorate?

In a gnotobiotic transplant model with a controlled microbial community, delayed microbial ammonia would precede cognitive impairment despite stable graft output and measured host clearance kinetics; changing microbial urease activity would transfer or abolish schedule sensitivity.

Explains the gap: Can individually adequate graft output and retained clearance become jointly unsafe after schedule disruption because their clocks cannot relock before cognition and self-care deteriorate?

In an animal model, impaired transport through brain tissue would explain cognitive deficits despite adequate clearance elsewhere. Slower removal of inert tracers and recovery when local fluid flow improves would support this claim; preserved local washout during impairment would reject it.

Explains the gap: Can individually adequate graft output and retained clearance become jointly unsafe after schedule disruption because their clocks cannot relock before cognition and self-care deteriorate?

The hypothesis says cognitive fluctuations in graft recipients are real, but a distinct failure of graft and host clocks to resynchronize is not. Better measurement and analysis should remove the graft-specific combined-challenge effect; a replicated effect with selective mechanistic rescue would reject it.

Explains the gap: Can individually adequate graft output and retained clearance become jointly unsafe after schedule disruption because their clocks cannot relock before cognition and self-care deteriorate?

In graft recipients, donor-reactive memory lymphocytes may remain active despite adequate treatment. Persistent injury and immune clones that decline after treatment targeting the resistant pathway would support this claim; recovery through simpler care and restored drug exposure would reject it.

Explains the gap: When molecular graft-injury signals rise, is stronger immune suppression correcting rejection or amplifying a workload-driven failure loop that simpler care could interrupt?

In graft recipients, unfinished care tasks could drive rejection despite prescribed treatment. With prescriptions unchanged, consolidating tasks should reduce overdue tasks, then gaps in drug exposure, then confirmed rejection; persistent exposure gaps or injury would point to rival mechanisms.

Explains the gap: When molecular graft-injury signals rise, is stronger immune suppression correcting rejection or amplifying a workload-driven failure loop that simpler care could interrupt?

In susceptible transplant recipients, calcineurin inhibitors may injure vessel linings despite correct dosing. The deciding observation is whether reducing culprit-drug exposure improves tissue injury, blood flow and absolute donor deoxyribonucleic acid (DNA) levels at comparable immune control.

Explains the gap: When molecular graft-injury signals rise, is stronger immune suppression correcting rejection or amplifying a workload-driven failure loop that simpler care could interrupt?

In a subset of fibrotic grafts, donor-reactive immune cells may remove senescent support cells and preserve blood flow. Suppressing these cells would reduce early donor-DNA release but worsen later function; restoring the same cells would reverse this while sparing working tissue.

Explains the gap: When molecular graft-injury signals rise, is stronger immune suppression correcting rejection or amplifying a workload-driven failure loop that simpler care could interrupt?

The hypothesis says gut microbial communities retain a state that inactivates tacrolimus before absorption. Low exposure despite observed dosing, plus persistent differences in drug conversion between cultures with different assembly histories under identical final conditions, would distinguish it.

Explains the gap: When molecular graft-injury signals rise, is stronger immune suppression correcting rejection or amplifying a workload-driven failure loop that simpler care could interrupt?

In the specified signal-positive subgroup, the donor share of deoxyribonucleic acid (DNA) rises because recipient DNA falls, creating an apparent graft-injury trend. Serial absolute measurements and independent tissue-injury measures distinguish this artifact from real injury.

Explains the gap: When molecular graft-injury signals rise, is stronger immune suppression correcting rejection or amplifying a workload-driven failure loop that simpler care could interrupt?

In middle-aged rodent muscle grafts, damage in retained attachments would explain why replacement order changes durability. Preventing later durability loss by unloading the attachment, and transferring that loss with damaged attachment material, would distinguish this mechanical explanation.

Explains the gap: Does a minimum beneficial anatomical set exist independently of replacement history, or do retained-tissue injury and niche depletion make the optimum path-dependent, potentially favoring no replacement?

In rodents, restoring lymphatic drainage before another graft would restore tracer clearance and graft durability if blocked drainage stores replacement history. Restored clearance without improved durability would falsify drainage as the dominant bottleneck.

Explains the gap: Does a minimum beneficial anatomical set exist independently of replacement history, or do retained-tissue injury and niche depletion make the optimum path-dependent, potentially favoring no replacement?

In superficial epithelial grafts, retained electrical patterns could make replacement order determine later graft behavior. Lasting recovery after a brief patterned voltage intervention, and lasting impairment after the inverse pattern, would distinguish this claim from its rivals.

Explains the gap: Does a minimum beneficial anatomical set exist independently of replacement history, or do retained-tissue injury and niche depletion make the optimum path-dependent, potentially favoring no replacement?

In mice with controlled microbial communities, this hypothesis means replacement history can affect later graft durability through gut microbes. Transfer of reduced durability by washed live communities, and removal of the sequence effect by standardizing recipient communities, would distinguish it.

Explains the gap: Does a minimum beneficial anatomical set exist independently of replacement history, or do retained-tissue injury and niche depletion make the optimum path-dependent, potentially favoring no replacement?

Apparently exhausted tissue may recover when a healthy earlier graft's maintenance demand is reversibly lowered. Paired recovery and energy-flow measurements would test whether grafts redirect energy away from distant tissue despite adequate nutrition and oxygen.

Explains the gap: Does a minimum beneficial anatomical set exist independently of replacement history, or do retained-tissue injury and niche depletion make the optimum path-dependent, potentially favoring no replacement?

In middle-aged animals, apparent loss of graft durability reflects treatment assignment and observation rules. Randomized replacement order with matched tissue and procedural exposure and synchronized assessment age would eliminate meaningful sequence differences; a reproducible effect would refute the claim.

Explains the gap: Does a minimum beneficial anatomical set exist independently of replacement history, or do retained-tissue injury and niche depletion make the optimum path-dependent, potentially favoring no replacement?

In an animal surgical model, the hypothesis predicts that a false repair-completed brain state persists after the drug clears. Reactivating injury-tagged insular ensembles—groups of neurons in the insular cortex—would restore repair; imposing the suppression-associated state would delay it.

Explains the gap: Could preventing postoperative delirium through inflammatory suppression worsen cumulative recovery by impairing repair or host defense, even when early cognition and inflammatory markers improve?

Retained fascia and fibroblasts around a wound may stay contractile after inflammation resolves. Preventing persistent activation and late contracture by keeping early strain below an estimated switching threshold, while preserving the delirium benefit, would support this claim.

Explains the gap: Could preventing postoperative delirium through inflammatory suppression worsen cumulative recovery by impairing repair or host defense, even when early cognition and inflammatory markers improve?

In controlled preclinical experiments, liver, muscle, and brain may become less able to withstand recovery stress. The deciding observation is whether correcting measured fuel-use defects restores cognition and physical reserve while pathogen burden and wound integrity are matched.

Explains the gap: Could preventing postoperative delirium through inflammatory suppression worsen cumulative recovery by impairing repair or host defense, even when early cognition and inflammatory markers improve?

Intensive or repeated suppression allows persistent or reactivated pathogens to expand despite early cognitive benefit. In preclinical models, eliminating pathogens would remove later recovery harm while preserving the early cognitive effect and anti-inflammatory exposure.

Explains the gap: Could preventing postoperative delirium through inflammatory suppression worsen cumulative recovery by impairing repair or host defense, even when early cognition and inflammatory markers improve?

The hypothesis predicts that early inflammatory suppression delays wound sealing and blood supply, impairing recovery even without infection. Restoring the missing repair signal locally would rescue recovery despite continued suppression throughout the body; exposure after closure would not have the same effect.

Explains the gap: Could preventing postoperative delirium through inflammatory suppression worsen cumulative recovery by impairing repair or host defense, even when early cognition and inflammatory markers improve?

In a component-randomized surgical trial, delirium benefit would track sedation or pain relief, while isolated inflammatory suppression would show neither benefit nor a meaningful recovery penalty. Reproducible early benefit and delayed harm from isolated suppression would reject this explanation.

Explains the gap: Could preventing postoperative delirium through inflammatory suppression worsen cumulative recovery by impairing repair or host defense, even when early cognition and inflammatory markers improve?